TAVR Bioprosthesis Thrombosis: Have Findings Changed Clinical Practice? - Azeem Latib, MD

↳ This is a section part of Moment: CRT 2016 Valve & Structural - Percutaneous Aortic Valves: Knowledge Gaps in a Maturing Technology

Add this Moment to your Passport

Learn from this moment and keep it forever.
add to passport
$19.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

TAVR Bioprosthesis Thrombosis: Have Findings Changed Clinical Practice? presented by Azeem Latib, MD at CRT 2016

Add this Moment to your Passport

Learn from this moment and keep it forever.
add to passport
$19.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Interventional Cardiologists 
  • Structural Heart Specialists 
  • Interventional Fellows 
  • Cardiac Surgeons 

Session Name: Percutaneous Aortic Valves: Knowledge Gaps in a Maturing Technology

Track: Track: CRT Valve & Structural

Learning Objectives

  • Update in advances/best practice in Valve & Structural procedures

Other Components in this Moment

Overview
TAVR Patient Populations Not Served with Current Indications - Michael Reardon, MD
Update to Leaflet Thrombosis Findings - Rajendra Makkar, MD, FSCAI
TAVR Bioprosthesis Thrombosis: Have Findings Changed Clinical Practice? - Azeem Latib, MD
Anticoagulation Post-TAVR: How Should We Find the Optimal Protocol? - Azeem Latib, MD
How to Assess Cognitive Impairment in Patients Undergoing TAVR - Ronald Lazar, PhD, FAHA
Surrogates Endpoint: Is it Sufficient to Support Approval and Clinical Use of Cerebral Embolic Protection Devices - Michael Mack, MD
Loading Simple Education